Table 3.
Intraoperative, postoperative and follow-up results of these 16 hepatoblastoma patients
| No. | Operation time (min) | Hepatic flow occlusion number and duration | Vascular reconstruction | Blood loss (mL) |
Blood transfusion during the operation
|
Post-operative AFP (ng/mL) | Margin | Pathology | Discharge time (d) |
Follow-up
|
|||
|
RBC (U)
|
Plasma (mL)
|
CRYO (U)
|
Time (m)
|
Result
|
|||||||||
| 1 | 220 | 1, 15 min | - | 20 | 1 | 0 | 0 | 1075 | R0 | FE | 6 | 68 | Recurrence |
| 2 | 165 | 1, 15 min | - | 5 | 0 | 0 | 0 | 1.33 | R0 | MEN | 9 | 64 | |
| 3 | 190 | 1, 20 min | - | 20 | 0 | 50 | 40 | 505.9 | R0 | MEM | 14 | 61 | Recurrence |
| 4 | 185 | 1, 15 min | - | 5 | 0.5 | 0 | 0 | 1.37 | R0 | MEM | 9 | 52 | |
| 5 | 285 | 2, 20 + 10 min | IVC | 100 | 2 | 300 | 2 | 25.86 | R1 | MEM | 20 | 46 | |
| 6 | 245 | 2, 13 + 12 min | - | 50 | 1 | 100 | 2 | 0.87 | R0 | F | 21 | 42 | |
| 7 | 230 | 2, 15 + 10 min | - | 100 | 1 | 120 | 0 | 2.55 | R0 | FE | 13 | 40 | |
| 8 | 250 | 3, 13 + 12 + 8 min | IVC | 200 | 2 | 100 | 0 | 2517 | R0 | FE | 13 | 39 | Metastasis, death |
| 9 | 190 | 1, 15 min | - | 10 | 0.5 | 0 | 0 | 9.15 | R0 | FE | 10 | 33 | |
| 10 | 295 | 2, 15 + 10 min | - | 100 | 1 | 0 | 2 | 1.55 | R0 | MEM | 9 | 16 | |
| 11 | 280 | 2, 15 + 10 min | - | 100 | 2 | 0 | 0 | 3.29 | R0 | MEM | 15 | 16 | |
| 12 | 310 | 1, 15 min | - | 50 | 2 | 120 | 2 | 3.53 | R0 | F | 14 | 16 | |
| 13 | 255 | 1, 15 min | - | 50 | 1 | 0 | 0 | 1.84 | R0 | MEM | 11 | 15 | |
| 14 | 355 | 4 | IVC, MHV | 500 | 6 | 770 | 12 | 7.43 | R0 | FE | 20 | 9 | |
| 15 | 265 | 20 + 15 + 18 + 12 min | - | 100 | 1.5 | 0 | 0 | 1642 | R0 | FE | 11 | 9 | |
| 16 | 245 | 1, 20, 3, 15 + 15 + 9 min | - | 30 | 1 | 0 | 0 | 8.2 | R0 | F | 14 | 7 | Recurrence |
RBC: Red blood cell; CRYO: Cryoprecipitate; AFP: Alpha-fetoprotein; IVC: Inferior vena cava; MHC: Middle hepatic vein; F: Pure fetal subtype; FE: Fetal and embryonal subtype; MEM: Mixed epithelial and mesenchymal type.